©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 21, 2007; 13(3): 329-340
Published online Jan 21, 2007. doi: 10.3748/wjg.v13.i3.329
Published online Jan 21, 2007. doi: 10.3748/wjg.v13.i3.329
Table 2 Medications associated with the cholestatic-type damage
| Compound | Other injury | Comment |
| Cholestasis without hepatitis (canalicular/bland/pure jaundice) | ||
| Estrogens, contraceptive steroids and anabolic-steroids (Budd-Chiari, adenoma, carcinoma, peliosis hepatitis, adenoma, carcinoma) | ||
| Cholestatis with hepatitis (hepatocanalicular jaundice) | ||
| Amoxicillin-clavulanic acid | Chronic cholestasis | VBDS |
| Atorvastatin | Chronic cholestasis | |
| Azathioprine | Chronic cholestasis | |
| Benoxaprofen (withdrawn) | ||
| Bupropion | Chronic cholestasis | |
| Captopril, enalapril, fosinopril | ||
| Carbamazepine | Chronic cholestasis | VBDS |
| Carbimazole | ||
| Cloxacillin, dicloxacillin, flucloxacillin | ||
| Clindamycin | Chronic cholestasis | |
| Ciprofloxacin, norfloxacin | ||
| Cyproheptadine | Chronic cholestasis | VBDS |
| Diazepam, nitrazepam | ||
| Erythromycins | Chronic cholestasis | VBDS |
| Gold compounds, penicillamine | ||
| Herbal remedies: | ||
| Chaparral leaf (Larrea tridentate); Glycyrrhizin, greater celandine (Chelidonium majus) | ||
| Irbesartan | Chronic cholestasis | |
| Lipid lowering agents (“statins”) | ||
| Macrolide antibiotics | ||
| Mianserin | ||
| Mirtazapine | Chronic cholestasis | |
| Phenotiazines (chlorpromazine) | Chronic cholestasis | |
| Robecoxib, celecoxib | ||
| Rosiglitazone, oioglitazone | ||
| Roxithromycin | Chronic cholestasis | |
| Sulfamethoxazole-trimethoprim | Chronic cholestasis | VBDS |
| Sulfonamides | Chronic cholestasis | |
| Sulfonylureas (Glibenclamide, Chlorpropamide) | ||
| Sulindac, piroxicam, diclofenac, ibuprofen | ||
| Terbinafine | Chronic cholestasis | VBDS |
| Tamoxifen | Hepatocellular, peliosis Chronic cholestasis | |
| Tetracycline | Chronic cholestasis | |
| Ticlopidine & Clopidogrel | Chronic cholestasis | |
| Thiabendazole | VBDS | |
| Tricyclic antidepressants (Amitriptyline, Imipramine) | Chronic cholestasis | VBDS |
| Sclerosing cholangitis-like | Floxuridine (intra-arterial) | |
| Cholangiodestructive (primary biliary cirrhosis) | Chlorpromazine, ajmaline | |
- Citation: Andrade RJ, Robles M, Fernández-Castañer A, López-Ortega S, López-Vega MC, Lucena MI. Assessment of drug-induced hepatotoxicity in clinical practice: A challenge for gastroenterologists. World J Gastroenterol 2007; 13(3): 329-340
- URL: https://www.wjgnet.com/1007-9327/full/v13/i3/329.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i3.329